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Abstract
Background: Endovascular technique has benefits vis-a-vis surgical access to organs with less accessible anatomical
locations. To minimize surgical risk we propose a novel endovascular technique, to create parenchymal access through
endovascular methods.
Methodology/Principal Findings: We have developed, manufactured and tested an endovascular catheter with a depth
limiting collar and a penetrating tip that is used to perforate vessels, thereby creating a working channel to the extra-
vascular space. Computer simulations and subsequent interventions have been performed ex vivo and in vivo in both small
and large animals by testing different prototypes. All tests were designed for testing extravascular hemostasis and absence
of thrombo-embolic complications when exiting the vessels from the inside to the extra vascular space. We have deposited
prototypes after intervention in vascular walls over a period of 14 days in rat with no impairment on blood flow and no
signs of thrombo-embolic complications upon re-exploration (n=7). We have also incorporated the catheter system with
clinically available systems both in an ex vivo simulator setting and in a full scale clinical angiographical setting in rabbit
were no bleeding (0%) in any of the interventions performed (n=40). To prevent hemorrhage during termination of the
procedure, a hollow electrolysis detachment-zone leaves the distal tip in the vessel-wall after the intervention. This has also
been tested with absolute hemostasis in large animals (n=6).
Conclusions/Significance: We have developed and tested a new system for transvascular tissue access in simulations, ex
vivo and in vivo in small and large animals, integrating it with standard clinical catheters and angiographical environment,
with absolute hemostasis and without thromboembolic complications. In a clinical setting for stem cell transplantation,
local substance administration or tissue sampling, the benefit should be greatest in organs that are difficult or high-risk to
access with other techniques, such as the pancreas, the central nervous system (CNS) and the heart.
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Introduction
There is a trend towards minimally invasive techniques for
transplantation of stem cells, local administration of substances or
sampling from various organ systems. Most organs and tissues in
the body can be reached by needles with or without ultrasonic or
computerized tomography guidance. If that is not possible, open
surgery is an option as is stereotactic delivery assisted by modern
imaging techniques [1]. For organs with less accessible anatomical
location, parenchymal access can be associated with significant
surgical risks [2]. The development of endovascular micro-
catheter techniques has opened a possibility to reach virtually all
parts of the body via the ‘‘internal routes’’ that arteries and veins
constitute. This has led to the possibility to perform minimally
invasive transplantations [3,4].
Advancements in stem cell research have created a potential for
regenerative treatment strategy to a wide spectrum of diseases tested
both in experimental animal systems and in humans, e.g. diabetes
mellitus [5], Parkinson [6], ischemic heart disease [7], traumatic
brain injury [8] and stroke [9]. Preferably, minimally invasive
techniques for reaching a desired target organ should be used. In
one comparison of different techniques for administration to the
central nervous system following stroke, the most efficient way of
transplantation was intra-cerebral followed by intra-cerebroventri-
cular and then intravenous delivery [10]. In a previous study we
have also shown that the intra-arterial route gives a higher
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braininjurymodel[11].Toaccomplishsuccessfultransplantation of
stem cells, a few considerations must be made, e.g. accessibility to
target organ, cell-type, volume and success-rate in engraftment [3].
It is probable that some cells possess a homing feature mediated
through receptor-ligand interactions [12]. For cells with those
properties an intravenous route would possible be favorable giving
better distribution throughout the transplantation target zone [10].
In situations where the cellular engraftment rate after endovascular
administration is low and when a high anatomical specificity for the
engraftment is required, direct puncture of the parenchyma is
preferable. This can be done with guided percutaneous needle
puncture or in a combination with open surgery [13]. The
transvenous system described by Thompson et al. [14] adds a
possibility to, via large veins, administrate cells transvenously to the
heart. The design of their device with a large diameter catheter and
without a closure device for the penetration site, makes it usable
predominantly in large vessels on the venous side, more specifically
in the coronary sinus of the heart [14,15]. The pancreas is however
not reachable but it has been suggested that it would be of great
benefitifinsulinproducingcellscould be transplanted directly tothe
parenchyma [16].
We now propose a new method using an endo-luminal device
herein named Extroducer, for exiting the micro- or macrovascu-
lature throughout the body on both the arterial and the venous side.
The design and concept of the device is associated with Seldingers
original work describing the introducer [17]. A standard endovas-
cular clinical catheter system, including an introducer, a guide-
catheter and a microcatheter, is navigated within the vasculature to
any target organ. Once the microcatheter is in the desired location
within the microvasculature, the Extroducer system is advanced
through the microcatheter. The Extroducer then safely penetrates
the arterial or venous wall, as a nanocatheter, to reach the
extravascular space, e.g. the parenchyma of any desired organ. The
system thereby creates a working channel in order to be able to
administrate or sample cells and substances to/from the extra-vasal
space, and to make closure of the vessel wall safe. The rationale
behind this technique is to combine minimal invasiveness of an
endo-luminal approachwith an accurateadministration ina desired
anatomical location. The exact relation between a specified vessel
segment and a desired parenchymal target zone is today easily
recognized with modern imaging techniques.
In previous works with intravascular transplantation of cells,
there is little discussion about the control over cellular engraftment
location, or the somewhat unfavorable ratio between transplanted
and engrafted cells. The aim of this study and the development of
the Extroducer concept are to combine favorable properties
of minimal invasiveness with accurate and efficient engraftment of
stem cells, and additionally, to make local administration of any
substance, such as cytostatics, isotopes, growth factors, contrast
agents, puncture of cysts or sampling in difficult anatomical
locations possible.
Results
Extroducer concept
Interventions have been performed ex vivo and in vivo in both
small and large animals by testing Extroducer prototypes. All tests
demonstrate absolute extravascular hemostasis and absence of
thrombo-embolic complications when exiting the vessels from the
inside to the extra vascular space. We have deposited prototypes
after intervention in vascular walls over a period of 14 days in
small animals with no impairment on blood flow or signs of
thrombo-embolic complications upon re-exploration. We have
also incorporated the Extroducer system with clinically available
catheter-systems both in an ex vivo simulator setting and in a full
scale clinical angiographical setting in large animals.
We first tested the concept of performing an exit through an
arterial wall in the tail artery of the rat with a sharply cut nitinol
tube acting as both introducer and Extroducer. This showed that
no hemorrhage occurred in either penetration from outside and in
and vice versa from inside and out providing rationale for
expanding the study.
Stop design, hollow detachment zone and effects on
cells
Conceptual prototypes (fig. 1) formed the basis for further
testing by solving two problems; a depth limiting device for exact
control of the system in a clinical angiographical setting and a
detachment zone, thereby leaving the distal part as a plug in the
vessel wall to prevent hemorrhage and thus providing a closure
method after completion of the intervention. Prototypes were all
constructed by hand and electrolysis detachments in isotonic saline
solution were successful at 8 V in an average time of 20 seconds.
We tested mesenchymal stem cells in a nitinol system with the
smallest lumen diameter available (ID 0.10460.0127 mm) with
1700 mm length by counting viable/dead cells after passage. This
showed that 10% died, but the remaining 90% of the cells survived
and were possible to re-seed in vitro. We have also showed effect of
passage on stem cell cultures in a previous published paper, albeit
in a shorter nitinol tube[11].
We then performed ex vivo tests on longitudinally cut aortas
coupled to a loading cell for force measurements with the
Extroducer, scaffolded by iron tubing (fig. 2a). Initial penetration
by the sharp tip is achieved at 11 gram. Full force to penetrate the
vessel wall with the intrusion depth limiting collar is then applied,
augmented by the scaffolding iron tubing. The vessel wall gives
away at 45 gram. Computing a ratio between the forces needed for
initial penetration and a then the collar, in essence, an
overshooting of the system conveys that at least five times the
force is needed. Testing maximum application of force until
bending of the nitinol tubing occurred, showed that 20 mm
outside the iron scaffold, the maximum force is 17 gram. (Data
plot not shown). Therefore with regular plastic catheter scaffolding
of the Extroducer system, it is impossible to overshoot the intrusion
depth limiting collar past the vessel wall.
Flow simulations and simulator testing
After detachment of the distal tip, the inner lumen would be
open and could potentially cause hemorrhage in the target tissue.
We performed flow calculations through different radii of a distal
tip at a pressure of 200 mmHg depicted in the graph of figure 2b
illustrating a circular Poiseuille flow, filled symbols, and with
COMSOL Multiphysics calculations to integrate turbulent flow,
open symbols, through a 2 mm lumen length. In the graph, flow
rates of water, plasma and whole blood at 37uC and a
physiological hematocrit of 45 (Y-axis) are plotted against the
lumen radius (X-axis). Fluid mechanics states that the flow rate out
of the lumen varies as the fourth power of the radius.
Consequently, the flow rate quickly becomes small as the lumen
radius is reduced. At a radius of 50 micrometer, the results of the
two methods coincide but at higher radii; the open symbols show
lower flow rates because turbulent flow is taken into account in
calculations with COMSOL Multiphysics. In practical terms, this
gives an auto-sealing effect up to 100 mm radius where flow is in
the range of 100 ml per second at physiological blood pressures
before introducing coagulation in the model at low and/or
turbulent flow.
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graph illustrating velocity fields of circular Poiseuille flows, filled
symbols and COMSOL Multiphysics, open symbols, in an
Extroducer device having a 2 mm long lumen, wherein the
velocity fields of whole blood, at 37uC and a physiological
hematocrit of 45, driven by a pressure of 200 mmHg (Y-axis) are
plotted against different lumen radius (X-axis). Turbulence
reduces the velocity in the central part of the velocity fields. For
a radius of 50 micrometer, the result by COMSOL Multiphysics is
identical to the circular Poiseuille flow, indicating full laminar flow
for this geometry whereas the result by COMSOL Multiphysics is
slightly reduced compared to the Poiseulle flow at a radius of 100
micrometer and heavily reduced at radii of 150 and 200
micrometer, respectively. When simulating water flow (lower
viscosity than whole blood), with assistance of COMSOL multi-
physics, through the detached Extroducer with an inner luminal
radius of 100 mm (double that of our prototype), no laminar flow
was observed with a driving pressure of 300 mm Hg (39.9 kPa).
The Extroducer concept is thus compromised of a depth
limiting collar for adequate placing. Directly proximal to that is a
hollow detachment zone and when detached no leakage through
the interior lumen occurs for the smallest fabrications. For larger
diameters the lumen is sealed by pushing a cylinder to the
Extroducer tip prior to detachment. Integration was then tested in
our simulator environment of the human vascular tree connected
to rat carcasses. Navigations through the simulator system were all
successful with full compatibility towards the clinical setting.
Extroducer in vivo testing - small animals
Short term testing was performed in rat by creating arterial
access from the medial tail artery and performing the Extroducer
transvascular passage in either the subclavian or carotid artery
testing two different stages; the transvascular passage and the
deployment of a tip. No cases of intra-operative hemorrhage or
intra-luminal thrombosis occurred. Thus, the vascular penetration
procedure was uneventful and the vessel wall completely sealed
around the Extroducer thereby preventing leakage of blood. When
applying papaverin to resolve potential vasospasm due to the
penetration procedure, no hemorrhage or other complications
were observed over a 90 minutes period. The animals excluded as
non-successful navigations were all excluded on the basis of
navigation solely with the nitinol guide and plastic tubing prior to
advancement of the penetrating prototype.
Histological analyses of vessels (fig. 3) showed an average
penetration diameter of 70 mm for the smallest dimension tested
(outer diameter 193 mm60.0127 mm).
The group with deposited Extroducer tips lacking intrusion
depth limiting collars also showed absolute hemostasis during the
primary intervention. Fourteen days post intervention, this group
showed no signs of pain or discomfort. No signs of dissection of the
vessels or impairment of blood-flow distal to intervention sites were
observed and macroscopical analysis of the organ supplied by the
vessel, showed no infarcts. The flow simulations indicating absence
of blood-flow through the interior lumen was also tested in vivo by
cannulating the detached transvascularly positioned tip of the
prototypes with a nitinol mandrel. This was done to reassure that
even when removing clotting inside the prototype it still prevented
bleeding from inside the vessel to the extravascular space.
Furthermore, no signs of delayed hemorrhage were detected.
The Extroducer prototypes were found associated to the outside
vessel wall or in the extra-vascular space adjacent to the
penetration site, indicating that the deposited Extroducer tip is
actively ‘‘pushed’’ out of the vessel wall by the pressure gradient
when lacking a depth limiting collar.
Extroducer in vivo testing - large animals
The Extroducer system tested in large animals was manufac-
tured from a longer nitinol tube, 1700 mm vis-a `-vis 300 mm that
Figure 1. Principal design of the tip of the Extroducer. Different designs of intrusion depth limiting collars were tested for optimal stopping
ability in a safe manner. Here, a principal drawing of the design is depicted with an intrusion depth limiting collar.
doi:10.1371/journal.pone.0010449.g001
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evaluated the prototypes together with clinical standard catheters
and angiographic equipment in the rabbit. A plastic catheter
around the Extroducer was used to avoid cutting the clinical
microcatheter when advancing the Extroducer system, and for
additional isolation during detachment.
The Extroducer prototypes were visible at high magnification
fluoroscopy and thereby maneuvered into position. A slight amount
of pressure was required on the plastic catheter to advance it to the
desired vessel wall and thereafter the Extroducer was gently
advanced out to the extra-vascular space (Fig. 4) (n=40). No
hemorrhages (0%) were observed by simultaneous direct observa-
tion through a surgical microscope, and no hemorrhages, thrombo-
embolic complications or dissections were observed using high
resolutionangiographic series, duringand after the intervention. No
navigational problems were encountered with respect to Extroducer
prototype integration with clinical catheters.
Application of papaverin did not cause hemorrhage, as expected
based on the small animal testing. In high resolution angiographic
series obtained up to 90 minutes after perforation, no effects at the
perforation site or in the circulation distal to the penetration site
could be observed (Fig. 5). However, when deliberately provoking
bleeding by retracting the Extroducer prototypes without prior
detachment, hemorrhages were observed.
Finally, the electrolysis detachment was tested in rabbit (n=6).
After navigation to thedesignated intervention site, methylene blue or
contrastagent was deposited (Fig. 4), a tension of 8 V was applied and
the distal end detached after on average five minutes (range three to
nine minutes). This was also un-eventful without observation of
hemorrhage both from around the body of the distal tip or through
t h ei n n e rl u m e n .T h ep r o c e d u r ew a ss u c c e s s f u l l yp e r f o r m e db o t h
with simultaneous microscopic monitoring via surgical access, and
with fluoroscopical/angiographical guidance solely.
Discussion
Testing the different Extroducer prototypes in simulation, ex vivo
and in vivo both in small and large animals have shown that the
Extroducer design is a safe way of performing interventions in
Figure 2. Exvivoand simulation data from penetration forces and
blood-flow in the catheter lumen. In a. graph showing data from a
loading cell connected to a longitudinally cut aorta mounted in free air
with the first bar corresponding to force applied to penetrate the vessel
wall from inside and out and the second bar corresponding to perforation
bythedepthlimitingcollar,an‘‘overshooting’’ofthesystem.Errorbars are
Standarddeviations.Inb. graph showingflow rates (Y-axis) plotted against
lumen radius (X-axis). The flow rate becomes small as the lumen radius is
reduced. At radii over 50 micrometer, turbulent flow gives lower flow rates
(open symbols) which is taken into account in the calculations with
COMSOL Multiphysics as compared to a perfect laminar flow (filled
symbols). In c. graph illustrating velocity fields of circular Poiseuille flows
(filled symbols) andCOMSOL Multiphysics(open symbols) in an Extroducer
device with a 2 mm long lumen, wherein the velocity fields, driven by a
pressure of 200 mmHg (Y-axis), are plotted against different lumen radius
(X-axis). This shows turbulence impact in reducing the velocity in the
central part of the velocity fields. At a 50 micrometer radius COMSOL
Multiphysicsis identical tothe circular Poiseuille flow butat higher radii the
impact of turbulence becomes apparent.
doi:10.1371/journal.pone.0010449.g002
Figure 3. Histology of vessel perforation. Microphotograph
showing the vessel perforation made by the Extroducer body with an
outer diameter of 194 mm. The Extroducer makes a penetration that is
on average 70 mm in diameter, indicated by arrows in this histological
vessel sample stained by hematoxilin and eosin. VW indicates vessel
wall and VL indicates vessel lumen, respectively. Scale bar: 20 mm.
doi:10.1371/journal.pone.0010449.g003
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endovascular technique. The novel design of the system in this
study combines the minimally invasive properties of endovascular
intervention and the creation of a working channel similar to an
open surgical or percutaneous approach. One of many possible
applications is optimal transplantation of insulin producing b-cells
which hitherto has been performed by intraluminal injection in the
portal vein[2,16]. We hypothesize that our system could add the
benefit of a more accurate placement of the cells while avoiding
the surgical risks of open transplantation.
From the small animal tests we conclude that it is an intrinsic
property of the vessel to prevent hemorrhage for Extroducer
perforations. We further conclude that with today’s limitations for
endovascular tubing, the Extroducer principle works for vessels
with diameters down to around 0.5 to 1 mm. However, we assume
that this property applies to vessels of all sizes based on experiences
from clinically used introducer systems.
The rationale for the intrusion depth limiting design is that,
even in high magnification fluoroscopy, the resolution for optimal
control is not sufficient. It is thus a safety precaution to avoid the
risk for overshooting the system. The dimension is designed, and
verified by the loading cell tests. Considering the forces measured,
it is actually impossible to reach levels needed for overshooting the
system because the nitinol in the body will bend without
scaffolding from a steel pipe; in the clinical system it is only
scaffolded by the SUBL tubing or a correspondently elastic
catheter. The Extroducer detached distal part can easily be made
long if the extra-vascular target zone is located far from the
penetrated vessel.
For the smallestfabrications of the Extroducer, blood flow through
the detached tip causing hemorrhages did not occur in vivo,a s
predicted by simulations. Furthermore, the risk of an inner lumen
blood-flow is heavily exaggerated in our computer simulations since
we assume a perfect flow entering the distal tip whereas in vivo,t h e
flow will be heavily turbulent upon entering the detached tip because
of the large angle between the blood vessel and the Extroducer.
Considering the tested dimension of the Extroducer system, it is
possible to perform these interventions in all vascularised parts of
Figure 4. Radiological and microsurgical examples of the intervention. For full control over the procedure in the large animal trials, both a
surgical microscope and high resolution angiographical series was used. In a. digital subtraction angiogram showing a detached Extroducer tip
without hemorrhage, dissection or thromboembolic complications. In b. photograph showing the microsurgical view of the detached Extroducer tip.
In c. x-ray image showing the detached Extroducer tip with guide catheter. In d. photograph from post-operative dissection showing the detached
Extroducer tip with methylene blue injected in the surrounding tissue. In e. digital subtraction angiogram showing an extra vascular injection of 25 ml
contrast agent through the Extroducer system.
doi:10.1371/journal.pone.0010449.g004
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even further primarily due to current standards in manufacturing
nitinol alloy tubing. A silicon based Extroducer could be
constructed even smaller but that would probably bring about
troubles when working with cells since exposing cell suspensions to
large shear stress would cause necrosis. Furthermore, the
Extroducer when placed inside a plastic tubing is small enough
to fit in standard micro-catheters allowing navigation to desired
areas with conventional techniques. The full scope of endovascular
guiding and micro-catheters available today is thus usable with the
current prototype size. On the other hand, the design of the system
allows for easy up-scaling which makes vascular exit possible also
in considerably larger luminal diameters. For larger Extroducer
dimensions, where a leakage would occur through the inner
lumen, a plug is advanced beyond the detachment zone, thereby
preventing hemorrhage. In further developments of the system,
the distal tip could be made in a biodegradable material.
Long term studies on vessel effects will be required for
evaluation of possible stenosis forming at the area of the detached
distal tip, thrombo-embolic complications or tracking of a
possible displacement of the tip itself. However, clinical
experience has shown that for example small nitinol wires or
stents protruding into the vascular lumen do not cause such
problems.
Figure 5. Follow up digital subtraction angiography. Digital subtraction angiography series in the subclavian artery at different time points
after detachment of the Extroducer tip.
doi:10.1371/journal.pone.0010449.g005
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Extroducer system is the ability to perform accurate placing of
engraftments and use smaller number of cells with minimally
invasive procedures. If a cell-type has a proven property of homing
only to a designated area, an intravenous/intra-arterial infusion
could be preferable. However, to minimize non-specific spreading
of transplanted cells and guarantee proper anatomical location,
the Extroducer has clear advantages.
For the purpose of administrating substances to organs with
difficult surgical access one can think of many applications ranging
from cytostatics, contrast agents, growth factors, isotopes etc. The
system could also be used for sampling procedures either for fluids
with small diameter applications of the system, or tissue/cells with
larger diameter applications combined with micro-forceps.
In conclusion, the novel design of the Extroducer prototypes has
sustained all testing so far. We consider the Extroducer, in a
potential clinical setting, a valuable tool for creating direct access
to all organs of the body with minimally invasive endovascular
technique for parenchymal access to perform stem cell transplan-
tations, cytostatics or contrast agent injections or cytological
sampling. The benefit should be greatest in organs that are difficult
or high risk to access with other techniques, such as the pancreas,
the central nervous system and the heart.
Materials and Methods
Ethic statement
All animal studies were conducted according to Karolinska
Institutet guidelines of animal experiments on small rodents and
rabbits. The studies were approved by the regional ethics
committee for animal research at the Karolinska University
Hospital (Stockholm, Sweden).
Initial testing of concept
The first testing of the concept was performed by sharpening an
ultra-thin super-elastic nitinol tube with outer diameter
0.193 mm60.0127 mm, inner diameter 0.10460.0127 mm
(Tube NiTi SE 508, ground surface, Euroflex GmbH, Germany)
and connecting this to a 50 ml micro syringe. This catheter was
then used to perforate a rat tail artery from the outside and then
immediately go through out via the opposing vessel wall.
Penetration depth limiting design
Design simulations were performed in COMSOL Multiphysics
software (Comsol AB, Sweden). Outer penetration depth limiting
designs were constructed with copper treading and tested
according to fig. 1. These stops were then tested in a system,
scaffolded by iron tubing (ID 270 mm), on rat aorta ex vivo, cut
longitudinally and hanging in free air between two connecting
points on a cork plate (n=10). Care was taken to perform this
immediately after dissection of the vessels so they would not dry.
The cork plate was connected to a loading cell 1004-300 (AB
Svenska va ˚g, Sweden) which in turn was connected to a weight
instrument LD5208 (AB Svenska va ˚g, Sweden) giving real time
output to a computer recoding the force applied in the
perpendicular direction of the inside of the vessel. Hereby forces
could be measured for vascular penetration with the grinded
nitinol tip and different depth limiting collars. Ratio calculations
could be performed between penetration by the distal portion and
different depth limiting designs.
Hollow detachment zone
To construct the hollow detachment zone and subsequent
simulation testing we used a 1700 mm long nitinol tube that was
cleaned with alcohol. For detachment zones, we applied parylene
through gas polymerization in vacuum in a 3 mm thickness
(ParaTech Coating AB, Sweden). Directly proximal from the
depth limiting collar a small insulation defect was cut through the
parylene. For in vitro testing, prototypes were submerged in isotonic
solution with 8 V tension through an electrode (cathode) and
prototypes (anode) (n=20). A tension of 8 V was applied by an
external electrical source resulting in a circumferential dissolution
of the catheter where the cut in the parylene was made. The distal
penetration end was then separated from the proximal access
portion of nitinol tube. The system used in vivo was constructed in a
similar manner but the cathode was a needle placed in the hind
limb of the rabbit.
Stem cell survival in small dimensions
Effects on stem cells were tested as previously described [11].
Briefly, cells were passed through a 1700 mm Extroducer
prototype and live and dead cell ratios were calculated before
and after passage through the addition of Trypan blue to the cell
suspension (Invitrogen, United Kingdom) and counting four
square millimeters of living and dead cells in a Bu ¨rker chamber.
Flow simulations in small dimensions
Blood flow from inside the vascular tree out to the extra-
vascular space via the lumen of the prototypes was assessed with
two types of simulations. We performed calculations of a circular
Poiseuille flow[18] and another simulation by COMSOL Multi-
physics which takes into account turbulent flow, wherein we
included water, plasma and whole blood with a hematocrit of 45.
These fluids were assumed to have a viscosity of 6.17E-04 Pa?s,
1.5E-03 Pa?s and 3.2E-03 Pa?s respectively[18], all at 37uC. We
also performed velocity fields calculations of whole blood, driven
by a pressure of 200 mmHg for different lumen radius in both
COMSOL Multiphysics and with perfect circular Poiseuille flow.
Extroducer simulations and ex vivo experiments
A simulation environment were constructed to test 1700 mm
long superelastic nitinol alloy tubes with diameters as described
earlier inside standard clinical guide- and micro-catheter systems.
A simulator of the human femoral, illica, aorta, truncus coelicus
and hepatic artery was constructed by connecting plastic tubing of
decreasing size and mounting them on a plate. The distal end
corresponding to the hepatic artery was then introduced in rat
carcasses through the distal end of the abdominal aorta for ex vivo
testing. Standard 6 F clinical introducer, guiding catheter; Envoy
(Cordis, USA) and micro-catheter; Prowler Plus (Cordis, USA)
were used to navigate within the simulator. Herein we tested the
maneuverability of the system and if enough driving pressure
could be applied to penetrate vessel walls. This was done on two
rat aortas with approximately 30 penetrations each.
Extroducer in vivo testing, small animals
A total number of 19 male Sprague-Dawley rats (BW 240–
350 g; B&K Universal AB, Sweden) were included in the study.
Two groups of small animals were used. One group with five
animals that only tested hemorrhage in or around the interven-
tional area and a second group with seven animals with survival
time 14 days where we simulated detachment of the Extroducer
tip by leaving the distal portion through the vascular wall after
penetration to analyze relative long term effects.
Six non-successful navigation animals of the subclavian or left
common carotid artery were excluded from their groups and
euthanized via decapitation under the same anesthesia session.
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injection of 0.2 ml Hypnorm-Dormikum (1:1:2; Hypnorm (fenta-
nyl citrate 0.315 mg/ml, fluanisone 10 mg/ml, Janssen Pharma-
ceutical, Belgium): Dormikum (midazolam 1 mg/ml, Roche AB,
Sweden)). Prior to skin incision, 0.1 ml Marcaine (5 mg/ml,
AstraZeneca, Sweden) was injected subcutaneously in the area of
operation. Animals were anesthetized with 0.1 ml intra-muscular
Hypnorm before decapitation.
In the rat we tested a 300 mm long nitinol prototype that was
introduced through the rat tail artery within a plastic PTFE-190
Sub-Lite wall tubing (SUBL) with outer diameter of
48260.025 mm and inner diameter of 330625 mm (AgnTho’s,
Sweden). The plastic tubing was used to minimize damage to the
vascular tree by the sharp penetrating tip.
All small animal surgery was performed with a M651 operating
microscope (Leica AB, Sweden) coupled to a CCD camera (Sony
AB, Sweden).
Introduction of catheters were performed via the medial tail
artery. A small longitudinal incision was cut on the ventral part of
the tail through the skin and the fascia overlying the artery. A
ligature was used to secure the PTFE-190 tube containing nitinol
leader and then the catheter system was blindly navigated up
through the aorta.
For observation and usages of the Extroducer prototypes, open
surgical preparation of either the common carotid artery via a
small mid-line incision medially on the neck, or the subclavian
artery via an axillary exploration were performed. To maximize
surgical access and navigational success-rates both the major and
the minor pectoral muscles were cut.
After navigation to the common carotid artery or the subclavian
artery with the blunted nitinol tube inside the PTFE-190 tube, the
nitinol was exchanged for an Extroducer prototype thereby
protecting vessels from damage during navigation. After reaching
tip to tip, the Extroducer prototype was gently advanced through
thearterialwall(takingadvantageofthevesselsnon-linear anatomy)
(n=20). For all prototypes, tests to exclude vasospasm as a potential
hemostatic cause, were performed by soaking the perforated vessel
with papaverin (Recip AB, Sweden) and observed for 90 minutes.
Mechanical manipulation of the detached Extroducer was also
performed to provoke possible hemorrhage.
In the second group, the same operational techniques were used
but instead of the 300 mm long prototype a 2.5 mm long prototype
was advanced through the vessel wall using a nitinol pusher (n=7).
The prototypes, deployed through the vascular wall were then
cannulated with a nitiol wire (OD 90 mm, ground surface, Euroflex
GmbH, Germany) to remove formed cloths and detect possible
hemorrhage. Without outer hemostatic control and after applica-
tion of papaverin these animals were sutured both for re-attaching
the pectoral muscles and the skin and allowed to recover in home
cages. 14 days later they were re-explored and euthanized.
Extroducer in vivo testing, large animals
Two groups of rabbits were used in this study. In the first group
four animals were used for transvascular Extroducer perforations
were performed with fluoroscopical, angiographical and simulta-
neous open microsurgical monitoring with several interventions per
animal (n=40). In the second group four other animals were subject
to Extroducer perforations performed with fluoroscopical and
angiographical monitoring only, followed by methylene blue- and
contrastagent injection throughthe nitinoltubeat aflowrateof2 to 5
microliters per second. The procedures were finished by detaching
the distal Extroducer portion by electrolysis and removing the
catheter system (n=6). Post-euthanasia dissections were performed.
Surgical anesthesia was induced by subcutaneous injection of 0.5 ml/
kg Hypnorm (fentanyl citrate 0.315 mg/ml, fluanisone 10 mg/ml,
Janssen Pharmaceutical, Belgium) combined with 5 mg diazepam.
An intravenous line was established in the ear veins bilaterally. A
bolus dose of Propofol was administered and thereafter, the rabbit
was intubated with a size 3 pediatric tube and connected to a Siemens
900 servo ventilator (Siemens Healthcare, United Kingdom). The
animal was infused with propofol according to standard rabbit doses,
i.e. 22 mg/ml/h. In addition, 0.1 ml of Hypnorm was injected
intravenously every 30 minutes. For euthanizing the rabbits, intra-
venous Pentobarbital overdoses were used.
All large animal angiography and surgery was performed with a
Philips XD20 angiographical equipment (Philips medical system,
Netherlands) and a OPMI6-DF operating microscope (Carl Zeiss AB,
Sweden) connected to a CCD camera. Visipaque 270 contrast agent
(GE healthcare, USA), was used in all angiography applications.
The femoral artery of the anesthetized rabbit was exposed
surgically and a 5 French Introducer was inserted in the artery
(Terumo, USA). Under fluoroscopic and angiographic control, a 5
French Envoy guiding catheter (Cordis Corporation, USA) was
navigated to different parts of the vasculature of the rabbit. A
Prowler Plus microcatheter (Cordis Corporation, USA) or
Renegade micro-catheter (Boston Scientific, USA) was inserted
within the Envoy guiding catheter and together with a Transend
Platinum Tip guidewire (Boston Scientific, USA) navigated under
angiographic control to the microvasculature (0.5–1 mm in lumen
diameter) in different parts, of the rabbit. After having reached the
desired target location, the guidewire was withdrawn from the
Prowler Plus microcatheter and the Extroducer within a PTFE-
190 Sub-Lite wall was inserted and deployed through the arterial
wall. This was performed both under direct visual control with
surgical microscope and under high magnification fluoroscopic
control with subsequent digital subtraction series. Injections with
methylene blue and contrast agent were performed to additionally
prove the concept of substance administration to the extra vascular
space. Perforations were followed up to 90 minutes by high
resolution digital subtraction angiographical series.
Tissue preparation and Histochemistry
Vessels were clamped, cut and fixated for 72 hours in 4%
buffered paraformaldehyde at 4uC. They were placed in 15%
sucrose for 24 hours at 4uC following the fixation procedure. The
vessels was then mounted on a holder and frozen in a Leica
cryostat (CM 3000, Leica Instruments GmbH, Germany). They
were covered with mounting medium and cut in 10 mm sections
and thaw mounted onto Super Frost/Plus object glasses (Menzel-
Gla ¨zer, Germany). The sections were stained with Hematoxylin
and Eosin[19]. Slides were then analyzed with a Leica DM 4000 B
microscope and photographed with a coupled Leica DFC 320
CCD camera. Quantification of perforations in vascular wall was
measured using ImageJ (Open-source software, NIH, USA).
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